Treatment of ocular cicatricial pemphigoid with the tumour necrosis factor alpha antagonist etanercept.
Prey
Sorilla
S
Robert
Pierre-Yves
PY
Drouet
Mireille
M
Sparsa
Agnés
A
Roux
Cyril
C
Bonnetblanc
Jean-Marie
JM
Bédane
Christophe
C
D000369:Aged, 80 and over; D000068800:Etanercept; D005128:Eye Diseases / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D010390:Pemphigoid, Benign Mucous Membrane / Q000175:diagnosis / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept